Mansi Mehta
Psychiatric/Mental Health · Plymouth, MINPI 1609393735
Payments from drug & device makers
Across 79 payments — averaging $30.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$561
- AbbVie$395
- Otsuka America Pharmaceutical, Inc.$308
- Axsome Therapeutics, Inc.$244
- Neurocrine Biosciences, Inc.$156
- Corium, LLC$152
- plus $624 from 15 others
What the payments were for
- Food & beverage$2,439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $561 |
| AbbVie | 10 | $395 |
| Otsuka America Pharmaceutical, Inc. | 5 | $308 |
| Axsome Therapeutics, Inc. | 5 | $244 |
| Neurocrine Biosciences, Inc. | 7 | $156 |
| Corium, LLC | 7 | $152 |
| Lundbeck LLC | 5 | $99 |
| Alkermes, Inc. | 3 | $74 |
| Pfizer | 5 | $73 |
| Amarin Pharma, Inc. | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Idorsia Pharmaceuticals US Inc | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Boehringer Ingelheim | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Indivior Inc. | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$344
- VRAYLAR$250
- Auvelity$122
- REXULTI$122
- ABILIFY MAINTENA$121
- ABILIFY ASIMTUFII$121
How this compares
$2,439 in reported general payments places this provider in the 75th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $393 |
| Duloxetine Hcl | 13 | $272 |
| Trazodone Hcl | 21 | $272 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $242 |
| Escitalopram Oxalate | 22 | $160 |
| Paroxetine Hcl | 11 | $132 |
| Mirtazapine | 16 | $128 |
| Lamotrigine | 17 | $120 |
| Bupropion Hcl SrBupropion Hcl | 12 | $117 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $98 |
| Clonazepam | 21 | $62 |
| Alprazolam | 19 | $25 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Plymouth
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.